VIE •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeVIE
Market Capitalization18.19 mln
Float1.32 mln
Earnings Date09/17/2025
EPS
5.27
Strong
P / E
1.71
Deeply undervalued
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-11.13
Highly reliable
1-Year Forecast
50.00
Transformational upside
Relative Strength
2
/ 100
Severely lagging
Business Description
Marinomed Biotech AG is an Austrian company founded in 2006 that researches and develops medicines for viral and immune-related conditions, selling its products across Europe and beyond. Its current portfolio includes treatments for allergic rhinitis, inflammatory eye diseases, and respiratory infections. The company also offers development and testing services for pharmaceutical formulations through its Solv4U platform, and works alongside SPH Sine Pharmaceutical Laboratories as a technology partner.
